Compounds > rolipram
Page last updated: 2024-11-04

rolipram and Brain Swelling

rolipram has been researched along with Brain Swelling in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Rolipram is a multifaceted antiinflammatory and antithrombotic compound that protects from ischemic neurodegeneration in clinically meaningful settings."5.39The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis. ( Brede, M; Göb, E; Heydenreich, N; Kleinschnitz, C; Kraft, P; Meuth, SG; Schwarz, T, 2013)
"Rolipram is a multifaceted antiinflammatory and antithrombotic compound that protects from ischemic neurodegeneration in clinically meaningful settings."1.39The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis. ( Brede, M; Göb, E; Heydenreich, N; Kleinschnitz, C; Kraft, P; Meuth, SG; Schwarz, T, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Q1
Peng, Y1
Fan, L1
Xu, H1
He, P1
Cao, S1
Li, J1
Chen, T1
Ruan, W1
Chen, G1
Kraft, P1
Schwarz, T1
Göb, E1
Heydenreich, N1
Brede, M1
Meuth, SG1
Kleinschnitz, C1
Folcik, VA1
Smith, T1
O'Bryant, S1
Kawczak, JA1
Zhu, B1
Sakurai, H1
Kajiwara, A1
Staddon, JM1
Glabinski, A1
Chernosky, AL1
Tani, M1
Johnson, JM1
Tuohy, VK1
Rubin, LL1
Ransohoff, RM1

Other Studies

3 other studies available for rolipram and Brain Swelling

ArticleYear
Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 99

    Topics: Animals; Apoptosis; Benzamides; Brain Edema; Brain Injuries; Cyclic Nucleotide Phosphodiesterases, T

2018
The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis.
    Experimental neurology, 2013, Volume: 247

    Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Cytokines; Disease Models, Animal; Enceph

2013
Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.
    Journal of neuroimmunology, 1999, Jun-01, Volume: 97, Issue:1-2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Blood-Brain Barrier; Brain Edema; Centr

1999